EFH
UTHR icon

Eaton Financial Holdings’s United Therapeutics UTHR Stock Holding History

Eaton Financial Holdings’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,156
Closed -$332K – 133
2025
Q2 		$332K Buy
+1,156
New +$345K 0.1% 98

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Eaton Financial Holdings's UTHR Position: Q3 2025 in Review

Eaton Financial Holdings sold out of United Therapeutics (UTHR) in Q3 2025, closing a stake of 1,156 shares — an estimated $332K sold.

Eaton Financial Holdings first reported a position in UTHR in Q2 2025 and held it in 1 quarter. The position peaked at $332K in Q2 2025. 708 funds tracked by Wall St. Rank hold UTHR as of Q3 2025.

  • Eaton Financial Holdings reported no remaining United Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Eaton Financial Holdings sold 1,156 United Therapeutics shares in Q3 2025, an estimated $332K.
  • Eaton Financial Holdings first reported a position in United Therapeutics in Q2 2025 and held it in 1 quarter.
  • Eaton Financial Holdings's United Therapeutics position peaked at $332K in Q2 2025.
  • 708 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2025.

Based on Eaton Financial Holdings's 13F filing for Q3 2025, filed 17 Nov 2025.